Mild to Moderate Asthma
Mild to moderate asthma is a chronic condition that affects the airways, causing them to become inflamed and narrow, leading to difficulty breathing, wheezing, and coughing.
Asthma and COPD: GB-0895 Study
We are investigating the safety of a new drug, GB-0895, in patients with mild to moderate asthma and those with COPD. This study aims to understand how well the drug is tolerated in these groups.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes it hard to breathe, often caused by long-term exposure to irritants like cigarette smoke, leading to symptoms such as chronic cough and shortness of breath.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Charite Research Organisation GmbH
Berlin, Germany
IKF Pneumologie GmbH & Co. KG
IKF Pneumologie GmbH & Co. KG
Frankfurt am Main, Germany
The Fraunhofer Institute For Toxicology And Experimental Medicine ITEM
The Fraunhofer Institute For Toxicology And Experimental Medicine ITEM
Hannover, Germany
Sponsor: Generate Biomedicines Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.